Xiao Chu

3.8k total citations
121 papers, 2.9k citations indexed

About

Xiao Chu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Xiao Chu has authored 121 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pulmonary and Respiratory Medicine, 33 papers in Oncology and 27 papers in Molecular Biology. Recurrent topics in Xiao Chu's work include Lung Cancer Treatments and Mutations (25 papers), Lung Cancer Diagnosis and Treatment (17 papers) and Lung Cancer Research Studies (16 papers). Xiao Chu is often cited by papers focused on Lung Cancer Treatments and Mutations (25 papers), Lung Cancer Diagnosis and Treatment (17 papers) and Lung Cancer Research Studies (16 papers). Xiao Chu collaborates with scholars based in China, United States and Hong Kong. Xiao Chu's co-authors include Xuming Deng, Miaomiao Wei, Xinxin Ci, Xiaofeng Yang, Mingfeng Guan, Lanxiang Jiang, Na Chen, Haihua Feng, Qingjun Cao and Xianxing Xie and has published in prestigious journals such as Nature Communications, ACS Nano and PLoS ONE.

In The Last Decade

Xiao Chu

119 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiao Chu China 31 983 528 507 402 338 121 2.9k
Constantin Căruntu Romania 38 1.1k 1.1× 687 1.3× 260 0.5× 842 2.1× 283 0.8× 131 4.2k
Zuhair Mohammad Hassan Iran 35 1.3k 1.3× 733 1.4× 210 0.4× 298 0.7× 233 0.7× 192 3.6k
Ravikumar Aalinkeel United States 30 1.2k 1.2× 314 0.6× 199 0.4× 249 0.6× 231 0.7× 83 3.2k
Jie Feng China 42 1.5k 1.5× 345 0.7× 398 0.8× 185 0.5× 634 1.9× 166 4.6k
Daxiong Xiang China 36 1.8k 1.8× 353 0.7× 260 0.5× 233 0.6× 550 1.6× 112 3.6k
Lihua Li China 35 1.8k 1.9× 465 0.9× 242 0.5× 248 0.6× 305 0.9× 182 3.8k
Bernard Pipy France 37 1.1k 1.1× 1.0k 1.9× 372 0.7× 225 0.6× 211 0.6× 137 3.8k
Yanan Li China 34 2.3k 2.3× 660 1.3× 350 0.7× 473 1.2× 245 0.7× 262 4.4k
Xiaofei Shen China 28 953 1.0× 656 1.2× 194 0.4× 378 0.9× 138 0.4× 128 2.7k
Xinyue Wang China 29 1.6k 1.6× 299 0.6× 260 0.5× 292 0.7× 434 1.3× 172 3.2k

Countries citing papers authored by Xiao Chu

Since Specialization
Citations

This map shows the geographic impact of Xiao Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao Chu more than expected).

Fields of papers citing papers by Xiao Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao Chu. The network helps show where Xiao Chu may publish in the future.

Co-authorship network of co-authors of Xiao Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao Chu. A scholar is included among the top collaborators of Xiao Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao Chu. Xiao Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Chuang, Yao Liu, Xiao Chu, et al.. (2025). Modulation of host ATP levels by secreted bacterial effectors. Nature Communications. 16(1). 4675–4675. 2 indexed citations
2.
Chu, Xiao, Ziqin Deng, Shuofeng Li, et al.. (2025). Signatures of H3K4me3 modification predict cancer immunotherapy response and identify a new immune checkpoint-SLAMF9. Respiratory Research. 26(1). 17–17. 2 indexed citations
3.
Sun, Yu, Lidong Wang, Jing Jie, et al.. (2024). Acinetobacter nosocomialis utilizes a unique type VI secretion system to promote its survival in niches with prey bacteria. mBio. 15(7). e0146824–e0146824. 4 indexed citations
4.
Ye, Luxi, Xiao Chu, Jianjiao Ni, et al.. (2024). NGS-based Tissue-Blood TMB Comparison and Blood-TMB Monitoring in Stage-III Non-Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy. Cancer Investigation. 42(2). 165–175. 1 indexed citations
5.
Wei, Ran, Xiao Chu, Tao Fan, et al.. (2024). Tumor-derived KLK8 predicts inferior survival and promotes an immune-suppressive tumor microenvironment in lung squamous cell carcinoma. BMC Pulmonary Medicine. 24(1). 53–53. 2 indexed citations
7.
Yuan, Xun, Yue Zhou, Li Chu, et al.. (2023). The efficacy of thoracic radiotherapy in extensive stage small cell lung cancer with baseline brain metastases: a multi-institutional retrospective cohort study. Annals of Translational Medicine. 11(2). 60–60. 4 indexed citations
8.
Fan, Tao, Shan Muhammad, Xiao Chu, et al.. (2023). H3K4me3-related lncRNAs signature and comprehensive analysis of H3K4me3 regulating tumor immunity in lung adenocarcinoma. Respiratory Research. 24(1). 122–122. 4 indexed citations
9.
Wang, Yalong, Zhenlin Yang, Ping Chen, et al.. (2023). Genetic trajectory and clonal evolution of multiple primary lung cancer with lymph node metastasis. Cancer Gene Therapy. 2 indexed citations
11.
Deng, Yun, Yilin Zhang, Xiaopeng Li, et al.. (2022). A telomere-to-telomere gap-free reference genome of watermelon and its mutation library provide important resources for gene discovery and breeding. Molecular Plant. 15(8). 1268–1284. 112 indexed citations
13.
Zhang, Xiaofei, Xiao Chu, Kuaile Zhao, & Weixin Zhao. (2021). A Case of a Rare STRN-ALK Fusion in Esophagus Adenocarcinoma Exhibits Excellent Response to Crizotinib. 2021(2). 1–3. 1 indexed citations
14.
Li, Yida, Liqing Zou, Li Chu, et al.. (2021). Identification and Integrated Analysis of circRNA and miRNA of Radiation-Induced Lung Injury in a Mouse Model. Journal of Inflammation Research. Volume 14. 4421–4431. 10 indexed citations
15.
Zheng, Yujia, Zheng Zhou, Xiao Chu, et al.. (2021). A Novel Immune-Related Prognostic Model for Response to Immunotherapy and Survival in Patients With Lung Adenocarcinoma. Frontiers in Cell and Developmental Biology. 9. 651406–651406. 30 indexed citations
16.
Zhou, Yue, Fan Yu, Yang Zhao, et al.. (2020). A narrative review of evolving roles of radiotherapy in advanced non-small cell lung cancer: from palliative care to active player. Translational Lung Cancer Research. 9(6). 2479–2493. 10 indexed citations
17.
Chu, Xiao, Shuyan Li, Bingqing Xia, et al.. (2019). Patterns of brain metastasis immediately before prophylactic cranial irradiation (PCI): implications for PCI optimization in limited-stage small cell lung cancer. Radiation Oncology. 14(1). 171–171. 13 indexed citations
18.
Liu, Ning, Yuxue Jiang, Jintong Chen, et al.. (2018). IL-33 drives the antitumor effects of dendritic cells via the induction of Tc9 cells. Cellular and Molecular Immunology. 16(7). 644–651. 28 indexed citations
19.
Wang, Dongjiao, Sujun Gao, Jintong Chen, et al.. (2018). Dectin-1 stimulates IL-33 expression in dendritic cells via upregulation of IRF4. Laboratory Investigation. 98(6). 708–714. 8 indexed citations
20.
Chu, Xiao. (2000). Cellular adhesive molecular and the invasion and metastasis of neoplasm. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026